J Korean Bal Soc.  2003 Dec;2(2):170-174.

Immunohistochemical Identification of Phosphorylated Extracellular Signal-Regulated Kinase1/2 in Rat Vestibular Nuclei by Unilateral Labyrinthectomy

Affiliations
  • 1Department of Physiology, Wonkwang University School of Medicine and Vestibulocochlear Research Center at Wonkwang University Iksan 570-749, South Korea. mskim@wonkwang.ac.kr

Abstract

This study evaluated the expression of phosphorylated signal-regulated kinase1/2 (pERK1/2), which is one of the main factors regulating transcription of the cfos oncogene in neurons, in the vestibular nuclei of Sprague-Dawley rats following unilateral labyrinthectomy (UL). Surgical UL was performed to eliminate afferent signals from the peripheral vestibular receptors in the inner ear, under a surgical microscope, 2 hours after anesthesia. Significant numbers of pERK1/2 immunoreactive neurons were seen in the superior, medial, and inferior vestibular nuclei. There were more pERK1/2 immunoreactive cells in the vestibular nuclei contralateral than in the vestibular nuclei ipsilateral to the injured labyrinth, which resulted in significant asymmetric expression of pERK1/2 immunoreactive cells. Subsequently, the pERK1/2 immunoreactivity decreased rapidly, disappearing 90 min after labyrinthectomy. No pERK1/2 labeling was seen in the lateral vestibular nucleus. These results suggest that intracellular signal pathways for the activation of extracellular signal-regulated kinase in the vestibular nuclei are involved in lesion-neural plasticity in the vestibular system

Keyword

Labyrinthectomy; pERK1/2; Vestibular Nucleus; Vestibular compensation

MeSH Terms

Anesthesia
Animals
Ear, Inner
Neurons
Oncogenes
Phosphotransferases
Plastics
Rats*
Rats, Sprague-Dawley
Signal Transduction
Vestibular Nuclei*
Vestibular Nucleus, Lateral
Phosphotransferases
Plastics
Full Text Links
  • JKBS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr